Q4-FY26 · Pat Kotia
FY26 was never designed as a year of aggressive topline extension. It was a year of deliberate groundwork and on account of that, I'm pleased to say it has been a productive year.
SHREEGANESHREMEDIES / language trends
Read confidence between the lines.
Shree Ganesh Remedies · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q4-FY26 · Bundin Kotier
We have successfully completed the pilot trial for this project. This is an important milestone for us and one that we have been working towards over recent quarters.
Q4-FY26 · Bundin Kotier
SG is not going to be involved in any of the finished pharmaceutical products or small molecules. SG definitely wishes to be a name in the specialty chemical manufacturing and as a reliable Indian manufacturing partner.